Skip to main content
OpenTrials
Completed

NCT Number: NCT02728661

Patient-Centered Weight Loss Program for Knee Replacement Patients

PACE is a patient-centered weight loss program that was developed specifically for knee replacements based on input from stakeholders, including knee replacement patients, physical therapists, and orthopedic surgeons. In this pilot study, participants undergoing knee replacement will be randomized to either start a weight loss program before surgery (PACE) or after surgery (Delayed PACE). Both programs will receive a 14-week intervention and complete assessments at baseline (up to 6 weeks prior to surgery), 12 weeks after surgery, and 26 weeks after surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–79 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Northwestern University

Chicago, Illinois, 60611, United States

About this study

It is estimated that half of patients diagnosed with knee osteoarthritis (OA) will need a total knee replacement (TKR) during their lifetime. Of patients who need a TKR, 80-95% are overweight or obese. While patients are encouraged to lose weight, limited, if any, guidance is provided to achieve recommended weight loss. Many patients perceive that TKR is a necessary precursor for the initiation of weight loss. Yet, 66% of patients actually gain weight by 2 years after surgery. Patients undergoing TKR not only face unique barriers (i.e., pain, mobility limitations, motivation) to weight loss, but also have to balance pre- and post-operative concerns from physicians, surgeons, and rehabilitation specialists. To best accommodate the needs of both patients (pre- and post-TKR) and healthcare professionals (i.e., surgeon, physical therapist), patient and stakeholder engagement and activation is imperative in the development of a patient-centered weight loss intervention. Investigators completed 20 interviews with patients pre- and post-TKR and identified weight loss barriers, preferred intervention components (e.g., delivery method, contact frequency, self-monitoring modality) and patient-reported outcomes (e.g., physical function, pain) viewed as critical by patients. Investigators developed a patient-centered weight loss program (PACE) guided by these results and additional input from stakeholders to meet the needs of patients and healthcare professionals. PACE is a randomized pilot study comparing weight loss and patient-reported outcomes between PACE (program starting up to 6 weeks pre-TKR to 12 weeks post-TKR) and Delayed PACE (program starting 12 weeks post-TKR to 26 weeks post-TKR).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI between 25-45 kg/m2
  • Have a scheduled knee replacement at least 1 week away from baseline assessment
  • Obtain physician approval to participate
  • English speaking
  • willing to attend 3 in-person assessments.

Exclusion criteria

  • Have any contraindications to diet or weight loss
  • Undergoing simultaneous bilateral knee replacement or have a scheduled or anticipated knee replacement for the contralateral knee in the next 26 weeks
  • Have a mobility limiting comorbidity besides relating to TKR
  • Taking anti-obesity medications
  • Enrolled in a formal weight loss program
  • Have had or is planning to have bariatric/gastric/lapband surgery
  • Is planning to relocate out of the Chicago land area in the next 12 months.

Treatment and study plan

PACE

Behavioral

PACE is an 14 week behavioral weight loss intervention developed specifically for knee replacement patients that starts up to 6 weeks prior to surgery.

Delayed PACE

Behavioral

Delayed PACE is an 14 week behavioral weight loss intervention developed specifically for knee replacement patients that starts 12 weeks after surgery.

Primary outcomes

  1. Change in weight measured with a balance-beam scale

    Time frame: Change from baseline to 12 and 26 weeks

Secondary outcomes

  1. Change in physical function assessed by the timed up and go

    Time frame: Change from baseline to 12 and 26 weeks

  2. Change in pain measured by WOMAC

    Time frame: Change from baseline to 12 and 26 weeks

Other outcomes

  1. Change in physical activity objectively-measured with accelerometry

    Time frame: Change from baseline to 12 and 26 weeks

  2. Behavioral adherence assessed by session and self-monitoring completion

    Time frame: 26 weeks post-op

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

Registry information

Acronym: PACE

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Apr 5, 2016
Registry last updated
Oct 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.